tion can be used to encourage them to
become compliant again. “Our programs
include engagement components where
we endeavour to help patients when they
become non-compliant as told by the data
itself, as long as the patient has expressed
consent to be communicated to,” Gillis
said.
If a patient is unable to afford the drug
or the medication has no coverage, STI’s
cards and the technology behind those
cards reimburse at the point of dispensa-
tion so that payment is automatic and sim-
ple for the patient and for the pharmacy to
administer.
In addition, STI also provides patient sup-
port and financial services. “So when you
have patients initiated on a therapy and
they need to navigate that world of who
is going to pay for their drugs, including
insurance, governments and so forth, of-
tentimes the manufacturers will sponsor
programs and caseworkers will provide
that kind of support to patients,” Gillis said.
“Our products enable access and choice and financial assistance to patients who
are participating in the health-care landscape.” Tim Gillis, president and CEO
JUNE 2016
H
business elite canada
5
